1. Skip to Menu
  2. Skip to Content
  3. Skip to Footer

Molecular Systems Biology

 

Molecular Systems Biology publishes research and technological advances that reveal novel system-level insights in all areas of the molecular life sciences. Published jointly by Nature Publishing Group and EMBO, the journal offers immediate open access to its content. The Journal has a dedicated blog, The Seven Stones.

 

Scope

Molecular Systems Biology publishes full-length papers describing original research in the field of molecular systems biology, focusing on the analysis, integration and modeling of molecular and cellular phenomena.

 

Subject categories are listed on the journal's website.

 

Founded: 2005
Editorial offices: EMBO, Heidelberg
Published by EMBO and Nature Publishing Group
Published Open Access online

Licenses and copyright

Molecular Systems Biology does not take copyright from authors – authors retain the copyright to their work and grant EMBO an exclusive license to publish it. The only copyright held by EMBO is on the fully rendered published article in the journal.

 

The journal applies a number of licences to control the re-use of the content, including CC-BY 2.0 and CC-BY NC. We are aiming to offer more liberal licences for all OA content soon.

 

Bibliometrics
Impact Factor (2012): 11.3 (Thomson Reuters)
Immediacy Index (2011): 1.621 (Thomson Reuters)
SJR (2011): 5.8 (JournalM3trics)
SNIP (2011): 2.2 (JournalM3trics)
h5 (2007-2011): 66 (Google Scholar)

EMBO Molecular Medicine

 

EMBO Molecular Medicine is devoted to the rapidly developing field where clinical research and molecular biology meet. The journal publishes high quality research relevant to the understanding, prevention and treatment of human disease.

Scope

EMBO Molecular Medicine is a broad scope journal dedicated to the interface between clinical research and molecular cell biology helping to forge new links between clinicians and molecular biologists. Studies based on model organisms also fall within the scope of the journal, provided that the results presented are directly relevant to human disease.

 

Subject categories are listed on the journal's website.

Founded: 2009
Editorial offices: EMBO, Heidelberg
Published for EMBO by Wiley-VCH
Published Open Access online

 

Licenses and copyright

Authors retain the copyright to their work and grant EMBO an exclusive license to publish it. The only copyright held by EMBO is on the fully rendered published article in the journal.

We apply a number of licences to control the re-use of the content, including CC-BY 2.0 and CC-BY NC. We are aiming to offer more liberal licences for all OA content soon.

 

Bibliometrics
Impact Factor (2012): 7.8 (Thomson Reuters)
Immediacy Index (2011): 1.769 (Thomson Reuters)
SJR (2011): 4.2 (JournalM3trics)
SNIP (2011): 2.1 (JournalM3trics)
h5 (2007-2011): 26 (Google Scholar)

The EMBO Journal

 

The EMBO Journal has been EMBO's flagship publication for 30 years. With a scope that spans all areas of molecular biology, the journal has an international reputation for quality and originality.

Read more...

Scientific publications

 

The EMBO Scientific Publications have developed a fair and transparent process to rapidly publish important science. We will continue to innovate in publishing to address community needs.

 

The EMBO JournalEMBO ReportsMolecular System BiologyEMBO Molecular Medicine

 

 

Transparent process

 

  1. Transparent Review
    Referee reports are published in full but without attribution; no confidential comments; authors can exclude referees.
  2. Fast Process
    Editorial decisions on average within a week, referee comments within a month, publication possible in 2 weeks.
  3. Straightforward Submission
    No journal-specific formatting is required at submission.
  4. Scooping Protection
    Similar findings published by others during review or revision are not a criterion for rejection.
  5. Referee Cross-Commenting
    Referees comment on one another’s reports before the editor makes a decision.
  6. Single Round
    Papers rarely undergo more than one major round of revision; more than 90% of invited revisions are published.
  7. Informed Evaluation
    Detailed editorial decisions supported by the Editorial Board. Authors can discuss manuscripts with editors at any stage.
  8. Manuscript transfers
    Authors can select to transfer manuscripts with referee reports between the EMBO publications.
  9. Source Data
    Authors can publish source data alongside figures. Supplementary information is restricted to essential data supporting key claims.
  10. Cite the Source
    Reference to specific findings should cite research papers. Journals have unlimited reference lists.